No position
Will South Korea ETF (EWY) hit (LOW) $177 Week of July 13 2026?
Ends Jul 17, 2026- Implied probability
- 2.5%
- Current value
- $0.5
- Potential payout
- $20
- Potential profit
- $19.5
- Multiplier
- 40.00x
- User PnL
- -$6.1
Polymarket Trader
0xb96b...ddef
0xb96bb9688d0ebb6c6daee3fa74ceba2d88cbddef
Public profile Partial data Delayed sectionDelayed section
- Open value
- $10.5
- Realized PnL
- -$23.58
- Win rate
- 18.2%
- Open positions
- 2
- Closed positions
- 11
- Markets traded
- Unavailable
Current Predictions
Open positions
N
No position
Will Brazil reach the Quarterfinals at the 2026 FIFA World Cup?
Ends Jan 1, 1970- Implied probability
- 100%
- Current value
- $10
- Potential payout
- $10
- Potential profit
- $0
- User PnL
- $0.1
Resolved Context
Closed positions
N
No position
Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 5%-6.5%?
Ends Jul 28, 2026- Implied probability
- 67.5%
- Multiplier
- 1.48x
- User PnL
- $1.89
N
No position
Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 3.5%-5%?
Ends Jul 28, 2026- Implied probability
- 84%
- Multiplier
- 1.19x
- User PnL
- $0.48
Y
Yes position
Danaher (DHR) Q2 non-GAAP core revenue growth 3%-4.5%?
Ends Jul 21, 2026- Implied probability
- 29.5%
- Multiplier
- 3.39x
- User PnL
- -$0.8
No position
Will Tesla (TSLA) beat quarterly earnings?
Ends Jul 22, 2026- Implied probability
- 44.5%
- Multiplier
- 2.25x
- User PnL
- -$0.92
Y
Yes position
Danaher (DHR) Q2 non-GAAP core revenue growth <0%?
Ends Jul 21, 2026- Implied probability
- 3.8%
- Multiplier
- 26.32x
- User PnL
- -$1
N
No position
Danaher (DHR) Q2 non-GAAP core revenue growth <0%?
Ends Jul 21, 2026- Implied probability
- 96.2%
- Multiplier
- 1.04x
- User PnL
- -$1
Y
Yes position
Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 5%-6.5%?
Ends Jul 28, 2026- Implied probability
- 32.5%
- Multiplier
- 3.08x
- User PnL
- -$1.3
N
No position
Thermo Fisher (TMO) Q2 organic revenue growth (non-GAAP) 2%-4%?
Ends Jul 23, 2026- Implied probability
- 47.5%
- Multiplier
- 2.11x
- User PnL
- -$1.4
Y
Yes position
Thermo Fisher (TMO) Q2 organic revenue growth (non-GAAP) 2%-4%?
Ends Jul 23, 2026- Implied probability
- 52.5%
- Multiplier
- 1.90x
- User PnL
- -$2.41
Y
Yes position
Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?
Ends Jul 15, 2026- Implied probability
- 55.5%
- Multiplier
- 1.80x
- User PnL
- -$2.8
Y
Yes position
Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 3.5%-5%?
Ends Jul 28, 2026- Implied probability
- 16%
- Multiplier
- 6.25x
- User PnL
- -$14.31
Trades
Recent trades
Latest visible trades for this Polymarket trader.
- Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 3.5%-5%?No 67% 6 shares
- Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 3.5%-5%?Yes 19% 90 shares
- Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 3.5%-5%?Yes 27% 5.92 shares
- Will Tesla (TSLA) beat quarterly earnings?No 14% 18 shares
- Thermo Fisher (TMO) Q2 organic revenue growth (non-GAAP) 2%-4%?No 50% 20 shares
- Thermo Fisher (TMO) Q2 organic revenue growth (non-GAAP) 2%-4%?Yes 47.3% 76 shares
- Thermo Fisher (TMO) Q2 organic revenue growth (non-GAAP) 2%-4%?Yes 50% 5 shares
- Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 5%-6.5%?Yes 15% 5 shares
- Coca-Cola (KO) Q2 organic revenue (non-GAAP) growth 5%-6.5%?No 80% 9 shares
- Danaher (DHR) Q2 non-GAAP core revenue growth 3%-4.5%?Yes 25% 20 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.35B?Yes 56% 40 shares
- Danaher (DHR) Q2 non-GAAP core revenue growth <0%?No 85% 20 shares